These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 23159945)
1. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth. Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945 [TBL] [Abstract][Full Text] [Related]
2. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells. Zhang X; Leung YK; Ho SM Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
4. Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy. Wajapeyee N; Raut CG; Somasundaram K Cancer Res; 2005 Oct; 65(19):8628-34. PubMed ID: 16204029 [TBL] [Abstract][Full Text] [Related]
5. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142 [TBL] [Abstract][Full Text] [Related]
6. The role of HRK gene in human cancer. Nakamura M; Shimada K; Konishi N Oncogene; 2008 Dec; 27 Suppl 1():S105-13. PubMed ID: 19641496 [TBL] [Abstract][Full Text] [Related]
7. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954 [TBL] [Abstract][Full Text] [Related]
8. Transcription factor specificity protein 1 (SP1) and activating protein 2alpha (AP-2alpha) regulate expression of human KCTD10 gene by binding to proximal region of promoter. Liu R; Zhou A; Ren D; He A; Hu X; Zhang W; Yang L; Liu M; Li H; Zhou J; Xiang S; Zhang J FEBS J; 2009 Feb; 276(4):1114-24. PubMed ID: 19154347 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917 [TBL] [Abstract][Full Text] [Related]
10. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. Orso F; Penna E; Cimino D; Astanina E; Maione F; Valdembri D; Giraudo E; Serini G; Sismondi P; De Bortoli M; Taverna D FASEB J; 2008 Aug; 22(8):2702-14. PubMed ID: 18443366 [TBL] [Abstract][Full Text] [Related]
11. Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas. Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N Oncology; 2006; 70(3):212-21. PubMed ID: 16809940 [TBL] [Abstract][Full Text] [Related]
12. HRK inactivation associated with promoter methylation and LOH in prostate cancer. Higuchi T; Nakamura M; Shimada K; Ishida E; Hirao K; Konishi N Prostate; 2008 Jan; 68(1):105-13. PubMed ID: 18008329 [TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
14. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776 [TBL] [Abstract][Full Text] [Related]
15. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959 [TBL] [Abstract][Full Text] [Related]
16. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372 [TBL] [Abstract][Full Text] [Related]
17. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635 [TBL] [Abstract][Full Text] [Related]
18. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Du Y; Carling T; Fang W; Piao Z; Sheu JC; Huang S Cancer Res; 2001 Nov; 61(22):8094-9. PubMed ID: 11719434 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Douglas DB; Akiyama Y; Carraway H; Belinsky SA; Esteller M; Gabrielson E; Weitzman S; Williams T; Herman JG; Baylin SB Cancer Res; 2004 Mar; 64(5):1611-20. PubMed ID: 14996719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]